Been There Done That, Now What
Biden's Ron Burgundy Teleprompter Gaffe 1984'd By White House
Patterns
Is Repetition Underrated?
KING KHABY LAME SHINE TO THE TOP ON TIKTOK FAME Repeat rip-off offender D’Amelio has been publicly accused of stealing multiple times but
EP 26: Astral Nightmare
Paganini non ripete, Ataman si
L-16 Fold in the Magic
Chapter 35: Rotten Luck (Rebroadcast)
Episode 258 I'll Never Do Anything To Hurt You
How To Get Repeat Customers For Your Business
Walt Maddox 011222
#94: Amsterdam Tales Special Edition Pod (Featuring Marrakesh)
Why I Love FB and IG Ads (And You Will Too)
David Dillard 081021
What Has Been Shall Be, What Shall Be Has Been.
Ep. 636 - The Pit of Success: How Leaders Adapt, Succeed, and Repeat | Dave Jenningsngs
Chapter 1: Sweet Meat (Rebroadcast)
THE HEAT ON SOUNDFYR WITH D-A-DUBB POD69
NHL Playoff Preview (Rd. 2) - Central Division CAR v TBL
Chapter 32: One Lump of Sugar, Two Lumps of Thallium (Rebroadcast)
Play. Recycle. Repeat: How To Put The Kids Old Toys To Good Use
Who's Most Likely To
Welcome to 2020. Now duck! (repeat) | JUNKULTURE RADIO (12/01/2020)
Monday Nov 30: Hour 2 - Fangio on Broncos being repeat offenders, Garett Bolles gets paid, Kendall Hinton's NFL debut, Monday Night Football
Dr. Lecia Sequist on Molecular Marker Testing in Advanced NSCLC in 2013: What, Who, and When?
Dr. Sarah Goldberg: How Do You Discuss the Pros and Cons of Molecular Testing, with Potential Delays and Need for Rebiopsy?
Dr. Karen Kelly: What Molecular Markers Do You Routinely Send for in Your Patients with Advanced Non-Small Cell Lung Cancer?
Drs. Ross Camidge and Corey Langer: Who Do You Recommend Repeat Biopsy for if There Isn’t Enough Tissue for Molecular Testing?
Dr. Heather Wakelee: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing
Dr. Karen Kelly: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy
Dr. Geoffrey Oxnard: Are Patients or Payers Objecting to Repeat Biopsy?
Dr. Geoffrey Oxnard: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing
Dr. David Spigel: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing
Dr. Greg Riely: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing
Dr. Greg Riely: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy
Dr. Karen Reckamp: Recommending a Repeat Biopsy, at Initial Diagnosis or with Acquired Resistance to a Targeted Therapy
Dr. David Spigel: How Do You Discuss the Pros and Cons of Molecular Testing, with Potential Delays and Need for Rebiopsy?
Dr. Geoffrey Oxnard: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy
Dr. Rosalyn Juergens: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy
Dr. Sarah Goldberg: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy
Dr. Karen Kelly: My Approach to Repeat Biopsies For Advanced NSCLC Patients Who Have Insufficient Tissue for Molecular Testing
Dr. Ravi Salgia: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing?
Dr. Phil Bonomi: For Which Advanced NSCLC Patients Do I Recommend Repeat Biopsies If They Have Insufficient Tissue for Molecular Testing?
Dr. Phil Bonomi: Recommending a Repeat Biopsy with Acquired Resistance to a Targeted Therapy
Dr. Rosalyn Juergens: How Do You Discuss the Pros and Cons of Molecular Testing, with Potential Delays and Need for Rebiopsy?
Questions & Answers with Drs. Riely, Weiss and Sequist; Moderated by Dr. West
Repeat Biopsies & the Potential Value of Biologically-Informed Acquired Resistance Therapy
Understanding Acquired Resistance in ALK+ Lung Cancer
The Potential Value of Repeat Biopsies in Acquired Resistance
Scopri di più
Cerca
